These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 15166065)

  • 1. Teicoplanin induced drug hypersensitivity syndrome.
    Perrett CM; McBride SR
    BMJ; 2004 May; 328(7451):1292. PubMed ID: 15166065
    [No Abstract]   [Full Text] [Related]  

  • 2. First fixed drug eruption due to teicoplanin with a peri-oral distribution.
    Duong T; Hamel D; Benlahrech S; Le Quan Sang KH; Sauvé-Martin H; De Prost Y; Roujeau JC; Hadj-Rabia S
    J Eur Acad Dermatol Venereol; 2009 Sep; 23(9):1107. PubMed ID: 19302102
    [No Abstract]   [Full Text] [Related]  

  • 3. Glycopeptide-induced vasculitis--cross-reactivity between vancomycin and teicoplanin.
    Marshall C; Street A; Galbraith K
    J Infect; 1998 Jul; 37(1):82-3. PubMed ID: 9733391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Teicoplanin hypersensitivity syndrome.
    Lye D; Athan E; O'Brien D
    Int J Antimicrob Agents; 2007 Apr; 29(4):476-8. PubMed ID: 17298875
    [No Abstract]   [Full Text] [Related]  

  • 5. Teicoplanin-induced vasculitis with cutaneous and renal involvement.
    Logan SA; Brown M; Davidson RN
    J Infect; 2005 Oct; 51(3):e185-6. PubMed ID: 16230204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DRESS syndrome caused by teicoplanin and vancomycin, associated with reactivation of human herpesvirus-6.
    Tamagawa-Mineoka R; Katoh N; Nara T; Nishimura Y; Yamamoto S; Kishimoto S
    Int J Dermatol; 2007 Jun; 46(6):654-5. PubMed ID: 17550572
    [No Abstract]   [Full Text] [Related]  

  • 7. [Determination of the in vitro activity of 2 glycopeptides (vancomycin and teicoplanin) against methicillin-resistant Staphylococcus aureus of intrahospital origin].
    Gil M; Otth L; Wilson M; Arce E; Zaror A; Lizama V
    Rev Med Chil; 2000 Jan; 128(1):111-2. PubMed ID: 10883531
    [No Abstract]   [Full Text] [Related]  

  • 8. [Methicillin-resistant Staphylococcus aureus infection in a geriatric unit for acutely ill].
    Selva O'Callaghan A; San José Laporte A; Almirante Gragera B; Vilardell Tarrés M
    Med Clin (Barc); 1998 May; 110(17):678. PubMed ID: 9656216
    [No Abstract]   [Full Text] [Related]  

  • 9. Vancomycin versus teicoplanin in the therapy of experimental methicillin-resistant Staphylococcus aureus (MRSA) meningitis.
    Sipahi OR; Arda B; Yurtseven T; Sipahi H; Ozgiray E; Suntur BM; Ulusoy S
    Int J Antimicrob Agents; 2005 Nov; 26(5):412-5. PubMed ID: 16221540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nephrotoxicity of vancomycin in patients with methicillin-resistant Staphylococcus aureus bacteraemia.
    Shen WC; Chiang YC; Chen HY; Chen TH; Yu FL; Tang CH; Sue YM
    Nephrology (Carlton); 2011 Nov; 16(8):697-703. PubMed ID: 21707841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of infective endocarditis caused by methicillin-resistant Staphylococcus aureus: teicoplanin versus vancomycin in a retrospective study.
    Huang JH; Hsu RB
    Scand J Infect Dis; 2008; 40(6-7):462-7. PubMed ID: 18584532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Case of congestive heart failure associated with hypereosinophilia developed during antibiotics treatment].
    Sato T; Hagiwara K; Matsuno H; Akiyama O
    Arerugi; 2005 Oct; 54(10):1208-12. PubMed ID: 16407668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Teicoplanin-induced purpuric eruption with leukocytoclastic vasculitis.
    Uchida Y; Higashi Y; Kanekura T
    Eur J Dermatol; 2014; 24(6):689-90. PubMed ID: 25179378
    [No Abstract]   [Full Text] [Related]  

  • 14. Teicoplanin resistance in methicillin-resistant Staphylococcus aureus in an intensive care unit.
    Cepeda J; Hayman S; Whitehouse T; Kibbler CC; Livermore D; Singer M; Wilson AP
    J Antimicrob Chemother; 2003 Sep; 52(3):533-4. PubMed ID: 12888581
    [No Abstract]   [Full Text] [Related]  

  • 15. Teicoplanin nephrotoxicity: first case report.
    Frye RF; Job ML; Dretler RH; Rosenbaum BJ
    Pharmacotherapy; 1992; 12(3):240-2. PubMed ID: 1535125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerability of teicoplanin in 117 hospitalized adults with previous vancomycin-induced fever, rash, or neutropenia: a retrospective chart review.
    Hung YP; Lee NY; Chang CM; Lee HC; Wu CJ; Chen PL; Lee CC; Chung CH; Ko WC
    Clin Ther; 2009 Sep; 31(9):1977-86. PubMed ID: 19843487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Teicoplanin-induced skin eruption.
    Unal S; Ikizoglu G; Demirkan F; Kaya TI
    Int J Dermatol; 2002 Dec; 41(12):948-9. PubMed ID: 12492999
    [No Abstract]   [Full Text] [Related]  

  • 18. Experience with teicoplanin in the treatment of neonatal staphylococcal sepsis.
    Yalaz M; Cetin H; Akisu M; Yeniay B; Tunger A; Kultursay N
    J Int Med Res; 2004; 32(5):540-8. PubMed ID: 15458287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Confirmation of hetero-glycopeptide-intermediate Staphylococcus aureus resistance among methicillin-resistant S. aureus blood culture isolates.
    Rossney AS; O'Connell B; Hannan MM; Kenny F; Murphy P
    Ir Med J; 2005 Apr; 98(4):113-4. PubMed ID: 15938556
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy of continuous cleansing with teicoplanin on post-CABG methicillin-resistant staphylococcus aureus (MRSA) mediastinitis: report of a case.
    Sezai A; Shiono M; Inoue T; Hata M; Iida M; Niino T; Saito A; Hattori T; Wakui S; Soeda M; Negishi N; Sezai Y
    Ann Thorac Cardiovasc Surg; 2004 Jun; 10(3):191-4. PubMed ID: 15312017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.